Generic placeholder image

Current Computer-Aided Drug Design

Editor-in-Chief

ISSN (Print): 1573-4099
ISSN (Online): 1875-6697

Why so Few Drug Targets: A Mathematical Explanation?

Author(s): Kyaw Tun, Marta Menghini, Lina D'Andrea, Pawan Dhar, Hiroshi Tanaka and Alessandro Giuliani

Volume 7, Issue 3, 2011

Page: [206 - 213] Pages: 8

DOI: 10.2174/157340911796504297

Price: $65

Abstract

The apparently paradoxical lack of correlation between the huge increase in the discovery of new potential drug targets made possible by the post-genomic sciences and new drugs development has stimulated many different interpretations. Here we illustrate the general principle of redundancy of biological pathways on hand of simplified mathematical approaches applied to different models of biological regulation. The simulation was based on the analysis of the ‘ degree of autonomy’ of network architectures in which the possibility for an external stimulus (e.g. a drug) impinging into a specific node to be sensed by the entire network, and eventually amplified up to a macroscopic consequence, was demonstrated to be limited to strictly linear pathways. The implications of such a result for poly-pharmacology and computational approaches to drug development are described as well.

Keywords: Systems biology, multiple targets, drug development, pharmacology, networks, linear topology, Mitogen Activated Protein Kinase (MAPK) cascade, simulation, computational approaches, Michaelis-Menten paradigm


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy